| Aug 8 |
Cytokinetics GAAP EPS of -$1.31 misses by $0.37, revenue of $0.25M misses by $20.71M
|
| Aug 8 |
Cytokinetics: Q2 Earnings Snapshot
|
| Aug 8 |
Cytokinetics Reports Second Quarter 2024 Financial Results
|
| Aug 7 |
Cytokinetics Q2 2024 Earnings Preview
|
| Jul 30 |
Investors in Cytokinetics (NASDAQ:CYTK) have seen incredible returns of 381% over the past five years
|
| Jul 30 |
Cytokinetics Announces Call for Proposals for Corporate Giving Program
|
| Jul 25 |
Cytokinetics to Announce Second Quarter Results on August 8, 2024
|
| Jul 25 |
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?
|
| Jul 24 |
Cytokinetics' Aficamten: Heartfelt Potential Amid Market Woes
|
| Jul 16 |
Cytokinetics Announces Seven Upcoming Presentations at the European Society of Cardiology Congress 2024
|
